Stock 0DHC CARL ZEISS MEDITEC AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Carl Zeiss Meditec AG London S.E.

Equities

0DHC

DE0005313704

Market Closed - London S.E.
Other stock markets
 11:30:00 2024-04-26 am EDT 		5-day change 1st Jan Change
100.7 EUR +1.51% Intraday chart for Carl Zeiss Meditec AG +4.05% +2.15%
Apr. 24 CARL ZEISS MEDITEC AG : Gets a Buy rating from UBS ZD
Apr. 23 CARL ZEISS MEDITEC AG : Receives a Sell rating from JP Morgan ZD

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Sales forecast by analysts have been recently revised upwards.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • With an expected P/E ratio at 34.33 and 27.09 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company's enterprise value to sales, at 4.2 times its current sales, is high.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CARL ZEISS MEDITEC AG Stock Carl Zeiss Meditec AG
+2.15% 9.58B -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AFX Stock
  4. 0DHC Stock
  5. Ratings Carl Zeiss Meditec AG